Canaccord Genuity assumed coverage on shares of Livongo Health (NASDAQ:LVGO) in a report published on Monday, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $46.00 price objective on the stock.

Other analysts have also issued research reports about the company. KeyCorp initiated coverage on Livongo Health in a report on Monday. They set an overweight rating and a $46.00 price target for the company. Goldman Sachs Group initiated coverage on Livongo Health in a report on Monday. They set a buy rating and a $43.00 price target for the company. Leerink Swann began coverage on Livongo Health in a report on Monday. They set an outperform rating and a $50.00 price target for the company. Piper Jaffray Companies began coverage on Livongo Health in a research note on Monday. They issued an overweight rating and a $40.00 price objective for the company. Finally, Needham & Company LLC began coverage on Livongo Health in a research note on Monday. They issued a buy rating and a $42.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has a consensus rating of Buy and a consensus price target of $44.20.

NASDAQ:LVGO opened at $34.95 on Monday. Livongo Health has a 52-week low of $31.60 and a 52-week high of $45.68.

In other Livongo Health news, Director Hemant Taneja acquired 2,678,571 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was purchased at an average price of $28.00 per share, with a total value of $74,999,988.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was acquired at an average cost of $28.00 per share, with a total value of $87,970,260.00. The disclosure for this purchase can be found here.

Livongo Health Company Profile

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Recommended Story: Using the New Google Finance Tool

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.